Результаты поиска

Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia.

Daratumumab, a CD38 monoclonal antibody that has been FDA-approved to treat multiple myeloma, has acquired popularity and is used off-label for both auto- and alloantibody mediated disorders, particularly in refractory/resistant circumstances. Much of the published data for its use in pediatric blood disorders has been in post-transplant autoimmune cytopenias. Here we describe three patients in whom daratumumab was used outside of post-transplant autoimmune cytopenias, highlighting further potential uses of this medication.

Совпадение в полном тексте источника
… Ethics statement Written informed consent was obtained from all the involved participants and/or their legal guardians for the publication of any potentially identifiable data included in this article. Author contributions MP formulated the idea. …

Синдром неадекватного антидиерезного вторичного воздействия на миелому: доклад о деле и обзор литературы.

Синдром неадекватного антидиеразиса (SIAD) связан с различными заболеваниями. Однако, насколько нам известно, лишь несколько исследований сообщили о том, что в качестве потенциальной причины СИАД можно использовать множественные миеломы (ММ). Мы сообщаем о случае, когда гипонатремия была основным клиническим проявлением, диагностированным SIAD и впоследствии подтвержденным как множественная миелома. После антимиеломной терапии гипонатремия была успешно исправлена после получения гематологической реакции, классифицированной как очень хорошая частичная реакция (VGPR). Это дело способствует редко

Совпадение в полном тексте источника
… Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. …

A rare case of post-transplant lymphoproliferative disorder (Hodgkins lymphoma) post autologous stem cell transplantation: A case report and review of literature.

IntroductionPost-transplant lymphoproliferative disorders(PTLD) include a mix of rare yet life endangering complications.Case presentation and conclusionHere, we report a case of a 63-year-old man who was the victim of post-transplant lymphoproliferative disorder (Hodgkin's lymphoma). The patient was initially diagnosed with multiple myeloma, for which chemotherapy and the autologous stem cell transplant was carried out. Post transplant patient was stable but on a follow up visit 6 months after the transplant he presented with generalized lymphadenopathy.His subsequent workup was done includin

Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study.

IntroductionIn patients with transient thrombocytopenia being treated with high-dose chemotherapy followed by stem cell rescue-haematopoietic stem cell transplantation (HSCT), prophylactic transfusions are standard therapy to prevent bleeding. However, a recent multicentre trial suggests that prophylactic platelet transfusions in HSCT may not be necessary. Additionally, the potential overuse of platelet products places a burden on a scarce healthcare resource. Moreover, the benefit of prophylactic platelet transfusions to prevent clinically relevant haemorrhage is debatable. Current randomised

Hyperbaric oxygen therapy in the treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

INTRODUCTION: Hemorrhagic cystitis (HC) is a common complication after allogeneic hematopoietic stem cell transplantation (HSCT), characterized by inflammation and bleeding of the bladder. Hyperbaric oxygen therapy (HBOT) has been shown to be effective in the treatment of radiation-induced HC. However, the optimal treatment for HC after allogeneic HSCT has not yet been established. Furthermore, limited research has been conducted on the use of HBOT in this setting. This study aimed to evaluate the effectiveness and safety of HBOT in patients with late-onset HC after allogeneic HSCT. METHODS:

Текущее качество жизненных вопросников не имеет значения для оценки проблем QOL у многих пациентов миэломы в эпоху современной терапии: результаты обследования, проведенного с пациентами миэломы и специалистами в области здравоохранения миеломы.

Поскольку многие пациенты миеломы (ММ) живут дольше, поддержание качества жизни (КОЛ) стало важной целью лечения. В то же время широко используемые вопросники по общему качеству жизни (QOLQs) были разработаны по сравнению с 20 Много лет назад. В этом обследовании 224 Пациенты ММ и 48 К специалистам в области здравоохранения (ХЦП) была обращена просьба оценить актуальность и важность предметов КОЛ из 9 аттестованные, часто используемые MM QOLQs. Результаты этого обследования выявили значительные расхождения в восприятии пациентами из числа ММ и ХЦП важных и актуальных вопросов КОЛ. Несмотря на

Совпадение в полном тексте источника
… Written informed consent for participation was not required from the participants or the participants' legal guardians/next of kin in accordance with the national legislation and institutional requirements because participation of the survey was optional and participants were anonymised. …

Denosumab versus zoledronic acid for primary osteoporosis: a 36-month retrospective cohort study on bone mineral density changes.

OBJECTIVE: To explore and compare the clinical efficacy and safety of denosumab versus zoledronic acid for the treatment of primary osteoporosis. METHODS: This retrospective cohort study included 413 primary osteoporosis patients (denosumab, n = 198; zoledronic acid, n = 215). All received daily calcium (600 mg) and vitamin D (400 IU), representing the total combined daily intake from diet and supplements. The denosumab group received subcutaneous denosumab 60 mg every 6 months and the zoledronic acid group annual intravenous zoledronic acid 5 mg over 36 months. Outcomes assessed at baseline

Совпадение в полном тексте источника
… Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements. …

Действенность и безопасность слабых пациентов, проходящих курс лечения цилакабагеном автолекселем в реальном мире: Центр международного анализа крови и мозгового трансплантатата.

Цилтакабтаген (цилта-сел), антиклеточная антигенная химерика против рецептора Т-клектора (CAR-T) (CAR-T) терапия для рентгеновского/отвержденного миэломы (RRMMM). МЕТОДЫ: С использованием регистра международных исследований по трансплантации крови и костного мозга в рамках этого исследования была проведена оценка результатов получения слаборазвитыми пациентами коммерческих цита-селей с марта 2022 по декабрь 2023. Площадь была определена адаптированным упрощенным расчетом, включающим возраст, статус производительности и совпадающие показатели. Результаты: 541 больные, имеющие слабое состояние,

Совпадение в полном тексте источника
… All patients or their legal guardians provided informed consent for data collection and research use. These data are subject to a series of automated and manual quality checks producing high‐quality data for observational research. …

Воздействие транскутановой стимуляции голени на мозговую функцию у пациентов с избыточным мочевым пузырем: перспективное продольное самоконтрольное исследование.

ЦЕЛЬ: Данное исследование было направлено на изучение деятельности мозга и функциональных изменений в связи с транскутановой стимуляцией берцового нерва (TTNS) у пациентов с нейрогеническим сверхактивным мочевым пузырем (OAB) наряду с изменениями клинических симптомов. МЕТОДЫ: Это перспективное продольное самоконтрольное испытание, проведенное в Китайском научно-исследовательском центре реабилитации с 2024 по 2025 год, охватывало 15 взрослых с определённым симптомами нейрогенного OAB, связанного с повреждением спинного мозга или множественным склерозом. Функциональная магнитно-резонансная съем

Совпадение в полном тексте источника
… Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin. Author contributions ZW: Writing – original draft, Conceptualization. YX: Writing – original draft, Data curation. XLy: Writing – original draft, Formal analysis. …

NEAT1 lncRNA overexpression results in short-term progression and poor treatment outcome in childhood B-ALL.

Childhood acute lymphoblastic leukaemia (chALL) remains the most prevalent malignancy in children and adolescents. Improving risk stratification and providing personalized prognosis and treatment remain major clinical challenges. Herein, we analysed the clinical utility of NEAT1 lncRNA for the prognosis and prediction of treatment outcome of childhood B-cell precursor ALL (chB-ALL). NEAT1_1 isoform was quantified in bone marrow samples of chB-ALL patients at diagnosis (n = 160) and at the end of induction (n = 108) of ALL-BFM protocol, and in age-matched healthy children (n = 68). Relapse and

Совпадение в полном тексте источника
… CONSENT TO PARTICIPATE Informed consent was obtained from all parents or legal guardians of the children, prior to participation in the study. Supporting information Data S1. ACKNOWLEDGEMENTS The publication of the article in OA mode was financially supported by HEAL‐Link. …

Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States.

BackgroundManagement of chronic inflammatory demyelinating polyneuropathy (CIDP) is challenged by heterogeneity in severity, comorbidities, potential adverse effects, and treatment accessibility. This study aimed to elucidate treatment utilization among patients with CIDP in the United States (US) to identify potential unmet needs.MethodsAdult patients with CIDP were identified using Komodo Health's Healthcare Map™ (January 2016-December 2020). Descriptive statistics related to utilization of CIDP treatments over 1-year post-index were analyzed. Among patients who used immunoglobulin (Ig), chr

Совпадение в полном тексте источника
… Written informed consent to participate in this study was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and the institutional requirements. …

Computed tomography-based conventional imaging features and texture analysis characteristics of chemotherapy drug-related acute pancreatitis.

PurposeChemotherapy drug-related acute pancreatitis (CDRAP) is a rare adverse event that poses significant challenges to clinicians. This study aimed to describe plain computed tomography (CT)- and contrast-enhanced computed tomography (CECT)-based conventional imaging features and texture analysis characteristics of CDRAP.MethodsA total of 62 patients with initial clinical and/or biochemical evidence of pancreatitis and 34 patients with normal pancreatic manifestations who underwent CT during chemotherapy were retrospectively included. The diagnosis of CDRAP was established based on clinical,

Совпадение в полном тексте источника
… The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants’ legal guardians/next of kin because Requirements for informed consent were waived due to the retrospective design of the study and the use of …

Analysis of influencing factors and predictive model construction for platelet transfusion efficacy in hematological patients.

BACKGROUND: This study aimed to systematically analyze the independent risk factors for platelet transfusion refractoriness (PTR) in hematological patients, and to develop and validate a nomogram prediction model, thereby providing scientific evidence for personalized platelet transfusion strategies in clinical practice. METHODS: A retrospective cohort study was conducted involving 363 platelet transfusion episodes in hematological patients who received platelet transfusions at Deyang People's Hospital between January 2023 and August 2023. Comprehensive clinical data and laboratory parameters

Совпадение в полном тексте источника
… Written informed consent to participate in this study was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and the institutional requirements. …

Real-world results with IgPro20 for hypo- or agammaglobulinemia in Japan.

BackgroundSubcutaneous immunoglobulin is one of the standard treatments for hypogammaglobulinemia in primary immunodeficiencies (PID) worldwide. In Japan, IgPro20 (Hizentra® ; l-proline-stabilized 20% human subcutaneous immunoglobulin) is approved for agammaglobulinemia or hypogammaglobulinemia due to PID or secondary immunodeficiency (SID); however, its safety and effectiveness has not previously been assessed in a real-world setting.MethodsThis multicenter, open label post-marketing surveillance study was conducted between January 2014 and March 2019. Patients who received IgPro20 due to PID

Medium to long term follow-up of survival and quality of life in patients with primary tumors of the cervical spine: Experience From a large single center.

ObjectivesTo evaluate the survival and medium to long term health-related quality of life (HRQoL) of patients with primary cervical spinal tumors in a cross-sectional study and to identify any significant associations with demographic or clinical characteristics.MethodsPatients diagnosed with primary cervical spinal tumors were retrospectively enrolled and their clinical, radiologic, and follow-up data (specifically the EQ-5D questionnaire) were collected. Univariate and multivariate Cox time-dependent regression analyses were performed to examine the significance of certain variables on overa

New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.

Although chimeric antigen receptor T (CAR-T) cell therapy has proven to be effective in treating relapsed or refractory B-cell hematological malignancies, severe hematological toxicities remain an intractable issue. This retrospective study assessed the characteristics and risk factors of new-onset severe cytopenia following CAR-T cell infusion in 76 patients with r/r acute lymphoblastic leukemia. The rates of new-onset severe cytopenia were high, including severe neutropenia (SN) (39/56, 70%), severe anemia (SA) (35/66, 53%), and severe thrombocytopenia (ST) (31/64, 48%). Comparatively, cohor

Оценка роли высокомерных пресноводных данных в коррекции при проведении исследований в области множественных склерозов: тематическое исследование.

ЦЕЛЬ: С учетом того, что в прошлом в рамках многочисленных исследований по склерозу (МС) использовались ограниченные связующие устройства с использованием административных данных о состоянии здоровья населения, в настоящем кратком докладе дается оценка воздействия включения высокомерной косвенной информации о слиянии в исследования по склерозам. Для оценки изменений в оценках воздействия на связь между лекарственными препаратами, изменяющими болезни (ДМР), и смертностью от всех причин в группе MS из Британской Колумбии (БК), Канада, мы внедрили высокомерные и высокомерные методы оценки риска з

Аутоиммунные заболевания у пациентов с различными фенотипами ПХОС.

Полицистический синдром яичников (ПХОС) представляет собой общее разнородное состояние, характеризующееся репродуктивными расстройствами и значительным метаболизмом и другими сопутствующими факторами. Тем не менее взаимосвязь между аутоиммунными расстройствами и ПХОС до сих пор не прояснена. Поэтому цель настоящего исследования состоит в том, чтобы изучить спектр системных и аутоиммунных расстройств органов у большой группы пациентов, страдающих ПХОС, и изучить возможные взаимосвязи между различными фенотипами ПХОС и способностью к аутоиммунным расстройствам. МЕТОДЫ: Всего 1,249 :: женщины с П

Совпадение в полном тексте источника
… The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants' legal guardians/next of kin because Patient consent was waived by the Institutional Ethics Committee due to the retrospective character of the …

Posterior vertebral column resection: Exploring practical uses in clinical settings.

BACKGROUND: The purpose of this study was to present our experience in patients who had been treated with posterior vertebral column resection (PVCR) for various spinal deformities. METHODS: Thirty-seven patients who performed PVCR between 2015 and 2018 were evaluated retrospectively. The mean follow-up period was 24 months (range: 12-50 months). The demographic data of the patients, mean blood loss, amount of blood replacement, duration of operation, intensive care and hospitalization period, PVCR level, instrumentation level, amount of preoperative curvature, amount of postoperative curvatu

Совпадение в полном тексте источника
… If the patient is under 18, informed consent has been obtained from the parents or legal guardians of the children. Surgical technique Following routine posterior midline exposure, pedicle screws were surgically implanted. …

Characteristics and Outcomes of Patients with Partial Do Not Resuscitate Orders in a Large Community Hospital.

Background Formal writing of do not resuscitate (DNR) orders first appeared in the literature in the late 20th century. Recently, providers have also noticed the presence of partial DNR orders while caring for patients. We sought to determine the effect of these orders on the clinical outcomes of the patients. Methods The study was a retrospective chart review covering a period of approximately 30 months. Patients included in the study were over 18 years of age and had a partial DNR order (i.e., chemical code, do not defibrillate (DND), do not intubate (DNI), intubate only, no cardiopulmonary